fNIRS can robustly measure brain activity during memory encoding and retrieval in healthy subjects

Early intervention in Alzheimer’s Disease (AD) requires novel biomarkers that can capture changes in brain activity at an early stage. Current AD biomarkers are expensive and/or invasive and therefore unsuitable for use as screening tools, but a non-invasive, inexpensive, easily accessible screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Jahani, Sahar, Fantana, Antoniu L., Harper, David, Ellison, James M., Boas, David A., Forester, Brent P., Yücel, Meryem A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572719/
https://www.ncbi.nlm.nih.gov/pubmed/28842618
http://dx.doi.org/10.1038/s41598-017-09868-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572719/
https://www.ncbi.nlm.nih.gov/pubmed/28842618
http://dx.doi.org/10.1038/s41598-017-09868-w

Ejemplares similares